ACT losing to Cell Cure Neurosciences a (BioTime) company
As I mentioned in one of my comments, ACT is losing to Cell Cure Neurosciences, who is on track with Aged Related Macular Degeneration. In my opinion, ACT is losing it's controls on their patents, and technologies. It appears (not sure) that other companies are coping ACT patents and technologies THEN changing them slightly so it can appear that it their own patents and technologies. ACT need to act now.
No FDA approval and in Israel. Not going anywhere fast... they need trials in the US and Europe. They need to have patents and if they don't, they don't have a product. There is no indication that cellcure has anything going at this moment that represents a threat to ACT. So much nonsense on this board.